Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents

NCT05346731 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Ondansetron
DRUG: Dexamethasone
DRUG: Aprepitant
DRUG: Olanzapine

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology